Introduction:Basic information about CAS 1354744-91-4|Naloxegol oxalate, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Naloxegol oxalate |
|---|
| CAS Number | 1354744-91-4 | Molecular Weight | 741.820 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C36H55NO15 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | (4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol,oxalic acid |
|---|
| Synonym | More Synonyms |
|---|
Naloxegol oxalate BiologicalActivity
| Description | Naloxegol oxalate (NKTR-118 oxalate; AZ-13337019 oxalate) is an opioid-receptor antagonist[1]. |
|---|
| Related Catalog | Signaling Pathways >>GPCR/G Protein >>Opioid ReceptorSignaling Pathways >>Neuronal Signaling >>Opioid ReceptorResearch Areas >>Neurological Disease |
|---|
| Target | Opioid receptor[1] |
|---|
| References | [1]. Garnock-Jones KP, et al. Naloxegol: a review of its use in patients with opioid-induced constipation. Drugs. 2015 Mar;75(4):419-25. [2]. Yoon SC, et al. Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem. Patient Prefer Adherence. 2017 Jul 24;11:1265-1271. |
|---|
Chemical & Physical Properties
| Molecular Formula | C36H55NO15 |
|---|
| Molecular Weight | 741.820 |
|---|
| Exact Mass | 741.357178 |
|---|
| PSA | 201.37000 |
|---|
| LogP | 0.95700 |
|---|
| InChIKey | MNYIRXLCPODKLG-VUTNLTPYSA-N |
|---|
| SMILES | C=CCN1CCC23c4c5ccc(O)c4OC2C(OCCOCCOCCOCCOCCOCCOCCOC)CCC3(O)C1C5.O=C(O)C(=O)O |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| NKTR-118 oxalate |
| Naloxegol oxalate (USAN) |
| Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5α,6α)-, ethanedioate (1:1) (salt) |
| Naloxegol oxalate |
| (5α,6α)-17-Allyl-6-(2,5,8,11,14,17,20-heptaoxadocosan-22-yloxy)-4,5-epoxymorphinan-3,14-diol ethanedioate (1:1) |
| UNII-65I14TNM33 |
| 4,5α-epoxy-6α-[(3,6,7,12,15,18,21-heptaoxadocosyl)oxy]-17-(prop-2-enyl)morphinan-3,14-diol hydrogen ethanedioate |